Nearly 800 poultry health professionals from more than 25 countries will gather in Portland, Oregon, from July 29 to 31 for the 2025 conference of the American Association of Avian Pathologists.
What is the best way to safeguard poultry health across a wide range of production systems and management teams? That’s a question Rick Phillips, DVM, MAM, director of poultry professional services veterinarians at Boehringer Ingelheim, has explored for more than 25 years while working with live-production teams across the US.
One of the many challenges affecting layers is APEC, an opportunistic challenge that impacts at least 30% of commercial flocks in the US, resulting in decreased egg production, increased bird mortality and significant economic losses. Cargill Animal Nutrition has introduced Biostrong™ C-Protect
Every year, turkey producers lose more than $2 million to Histomoniasis (blackhead disease) alone due to high mortality rates and decreased flock performance. With limited industry investment to address turkey health challenges, turkey producers need solutions.
Using a dietary supplement containing a blend of Bacillus bacterial strains appears to positively affect the intestinal health and immunity of broiler chicks after a coccidia challenge, according to a Frontiers in Microbiology report.
Synthetic anticoccidials, also referred to as “chemicals,” are often considered the most efficacious tools to mitigate coccidiosis in poultry. Yet, despite their effectiveness, veterinarians and producers sometimes hesitate to incorporate them into control programs due to the concern of chemical-resistant Eimeria strains developing.
Saponins are well-known for their role in supporting bird performance, gut health and immune health. But in the latest research, scientists have uncovered greater insight into how different types of saponins, specifically quillaja, yucca and blends of the two, contribute to these outcomes.
USDA has authorized Boehringer Ingelheim to import two of the company’s live-virus vaccines for emergency use to help protect US poultry against avian metapneumovirus (aMPV) — a highly contagious respiratory viral infection that can result in severe respiratory symptoms and increased mortality in poultry.
Vaccines are essential tools for managing diseases in poultry and ensuring flock welfare. Taking shortcuts with them is never a good idea, however, and there’s plenty of research to prove it. In the second of a two-part series, Bill Stanley, DVM, and Isabel Gimeno, DVM, PhD, talked about their experiences managing vaccines and ensuring optimum performance.
Immunosuppression is a costly yet often misunderstood problem in the poultry industry. But what exactly is immunosuppression, and how can it be detected, diagnosed and measured? In the first of a two-part series, Isabel Gimeno, DVM, PhD, and Bill Stanley, DVM, share their expertise on this topic.
More than 6 million birds have been vaccinated against avian metapneumovirus (aMPV) type B since the September rollout of the first experimental autogenous vaccine produced in the US, according to Ivan Alvarado, PhD, associate director, scientific marketing affairs, Merck Animal Health.
Avian metapneumovirus (aMPV) is now the leading health issue facing the US turkey industry, according to a recent survey of turkey industry professionals and veterinarians representing 73% of the 218 million birds raised in the US over 12 months ending August 2024.
[random-sponsor]
Copyright ©Feeks Media LLC, 2025 | All rights reserved
info@modernpoultry.media
privacy policy | site map
